Lifeway Foods stock reports 24.10 percent Q2 revenue growth

Lifeway Foods stock is anchored by Q2 2026 revenue of USD 66.89 million, a 24.10 percent year-over-year increase. The stronger sales figure contrasted with diluted EPS of USD 0.01 against a USD 0.26 consensus estimate, putting margin performance at the center of the investment case.

Revenue growth meets earnings pressure

According to Investing.com on August 13, 2026, Lifeway reported record Q2 sales of USD 66.9 million, up 24.10 percent year over year, while net income fell to USD 0.1 million and EPS reached USD 0.01. The same summary identified a gross margin of 19.50 percent, with higher milk prices, packaging resin costs and transportation expenses weighing on profitability.

The comparison is unusually sharp: revenue exceeded the USD 61.40 million consensus estimate by USD 5.49 million, while EPS missed the USD 0.26 forecast by USD 0.25. That split gives investors two different signals from the same quarter, with demand growth running ahead of earnings conversion.

Analyst target remains above the quote

Investing.com listed three buy ratings and no hold or sell ratings on September 29, 2026, producing a Strong Buy consensus and a USD 33.00 average 12-month price target. Its analyst table showed BTIG with a USD 32.00 target dated August 20, 2026, and Benchmark with a USD 35.00 target dated June 15, 2026.

The next scheduled earnings date is November 16, 2026, according to Investing.com. The date gives the market a defined checkpoint for testing whether Q2 sales momentum can translate into stronger profit.

Market value stands at USD 323.1 million

Lifeway Foods had a market capitalization of USD 323.1 million as of September 29, 2026, with a 52-week range of USD 17.31 to USD 32.71. The company is based in Morton Grove, Illinois, and its investor-relations page identifies Nasdaq ticker LWAY and a product portfolio centered on kefir and other probiotic foods, according to Lifeway Foods.